Micro-albuminuria: a predictor of 7-day mortality in acute myocardial infarction

Sanjay K Bandyopadhyay1, Soumitra Ghosh, Ranjana Bandyopadhyay

  • 1Department of Medicine, Nil Ratan Sircar Medical College, Kolkata.

Insights

Microalbuminuria (MA) is highly prevalent in acute myocardial infarction (AMI) patients. Elevated or persistent MA strongly predicts short-term in-hospital mortality and correlates with poor cardiac function in AMI survivors.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Acute myocardial infarction (AMI) poses significant mortality risks.
  • Identifying reliable prognostic markers for in-hospital mortality is crucial for patient management.
  • Microalbuminuria (MA) is increasingly recognized as a potential indicator of endothelial dysfunction and cardiovascular risk.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria (MA) in non-diabetic patients with acute myocardial infarction (AMI).
  • To investigate the significance of MA as a predictor of short-term in-hospital mortality.
  • To correlate MA with established prognostic markers like Killip's class and ejection fraction in AMI patients.

Main Methods:

  • A cohort of 80 non-diabetic AMI patients admitted within 24 hours of pain onset was studied.
  • Spot urinary albumin-to-creatinine ratio (ACR) was measured on days 1, 4, and/or 7.
  • Hemodynamic status (Killip's class) and ejection fraction were assessed, and 7-day mortality was recorded.

Main Results:

  • Microalbuminuria (MA) was detected in 95% of patients on day 1.
  • Higher MA values (>100 microg/mg) on day 1 were associated with significantly increased mortality (p <0.01).
  • Static or increasing MA from day 1 to day 4/7 correlated significantly with higher mortality (p <0.01) and deteriorating Killip's class.

Conclusions:

  • Microalbuminuria (MA) is a highly prevalent finding in acute myocardial infarction (AMI) patients.
  • MA is a reliable predictor of short-term in-hospital mortality in AMI.
  • MA levels correlate with impaired cardiac function and hemodynamic instability in AMI patients.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...